Sign inJoin waitlistJoin the waitlist

James Essell

Physician · Oncology Hematology Care Inc

Credentials: · · · · · ·

History

Oncology Hematology Care Inc
Present

Wilford Hall Ambulatory Surgical Center
1991–1993
Wilford Hall United States Air Force Medical Center at Lackland Air Force Base
1988–1991
Wilford Hall Ambulatory Surgical Center
1985–1988
University of Cincinnati College of Medicine
1981–1985

Research

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation…
The Lancet Oncology · 2022 · 223 citations
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation,…
The Lancet Oncology · 2018 · 179 citations
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
Journal of Clinical Oncology · 2021 · 169 citations

IF
Ian Flinn
8 papers
JR
James Reeves
5 papers
JB
Jesus Berdeja
5 papers
Daanish Hoda
4 papers
Guillermo Garcia-Manero
4 papers
Mikkael Sekeres
4 papers
SF
Suzanne Fanning
4 papers
CB
Carlos Bachier
3 papers
David Rizzieri
3 papers
DE
Drore Eisen
3 papers
EA
Edward Arrowsmith
3 papers
JS
Jeff Sharman
3 papers

Clinical trials

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Site PI · Recruiting · Phase 1
Caribou Biosciences, Inc.
2023–2027